Diversified Trust Co Trims Position in Centene Co. (NYSE:CNC)

Diversified Trust Co reduced its holdings in Centene Co. (NYSE:CNC) by 64.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,921 shares of the company’s stock after selling 18,018 shares during the quarter. Diversified Trust Co’s holdings in Centene were worth $601,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in CNC. Harris Associates L P raised its position in shares of Centene by 5.7% in the 3rd quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock worth $1,980,932,000 after buying an additional 1,420,825 shares during the period. State Street Corp raised its holdings in shares of Centene by 0.5% in the 3rd quarter. State Street Corp now owns 23,468,159 shares of the company’s stock worth $1,766,683,000 after purchasing an additional 111,654 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Centene by 3.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,768,534 shares of the company’s stock valued at $434,255,000 after purchasing an additional 194,566 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Centene by 14.2% during the 2nd quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock worth $339,042,000 after purchasing an additional 636,683 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in Centene by 8.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,707,648 shares of the company’s stock worth $312,150,000 after purchasing an additional 385,426 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Stock Down 2.3 %

NYSE:CNC opened at $61.72 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. The company has a market capitalization of $31.16 billion, a price-to-earnings ratio of 10.72, a price-to-earnings-growth ratio of 0.78 and a beta of 0.45. Centene Co. has a one year low of $55.03 and a one year high of $81.42. The stock has a 50-day simple moving average of $60.09 and a 200 day simple moving average of $67.45.

Analyst Ratings Changes

CNC has been the subject of several research reports. Stephens decreased their price objective on shares of Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a research note on Friday, December 13th. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $75.00 price objective (down from $80.00) on shares of Centene in a research report on Tuesday, December 17th. Robert W. Baird lowered their target price on Centene from $83.00 to $66.00 and set a “neutral” rating for the company in a research note on Friday, October 25th. Wells Fargo & Company reduced their price target on Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $90.00 price objective on shares of Centene in a research report on Wednesday, December 11th. One analyst has rated the stock with a sell rating, four have given a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, Centene has an average rating of “Moderate Buy” and an average price target of $80.92.

Insider Transactions at Centene

In related news, CFO Andrew Lynn Asher bought 17,200 shares of the firm’s stock in a transaction on Wednesday, November 13th. The stock was bought at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the purchase, the chief financial officer now directly owns 486,847 shares in the company, valued at approximately $28,305,284.58. The trade was a 3.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sarah London purchased 4,117 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the acquisition, the chief executive officer now owns 667,229 shares in the company, valued at approximately $40,567,523.20. The trade was a 0.62 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders bought 45,010 shares of company stock worth $2,660,276. 0.33% of the stock is currently owned by corporate insiders.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.